Subscribe to the Drug Discovery & Development (DDD) Newsletter
Drug Discovery and Development
Renaissance Pharma secures FDA Fast Track Designation and IND clearance for Daretabart in high-risk neuroblastoma
The US Food and Drug Administration (FDA) has granted Fast Track Designation for Daretabart (hu1418K322A), a novel anti-GD2 monoclonal antibody in development for the...
Oragenics doses first patient in phase 2a clinical trial of drug for mild traumatic brain injury
Oragenics, a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, has announced that the first patient has been dosed in its...
Bracco invests in GMP manufacturing facility for cell therapy products
Bracco Imaging, a global pharmaceutical company that develops, manufactures, and markets innovative healthcare solutions, announced an upgrade of its manufacturing site in Geneva to...
Virica Biotech and Fujifilm Biosciences collaborate to develop production enhancers
Virica Biotech, a cell enhancer company specialising in Viral Sensitizers for viral vector manufacturing, has announced receipt of advisory services and funding from the...
FDA approves new high dose regimen of Spinraza (nusinersen) for spinal muscular atrophy
Biogen has announced that the high dose regimen of Spinraza® (nusinersen), which is comprised of 50 mg/5 mL and 28 mg/5 mL doses, has been approved...
Apotex receives first US FDA tentative approval for a generic version of Ozempic (semaglutide injection)
Apotex has announced it has received the first US Food and Drug Administration (FDA) Tentative Approval for its Abbreviated New Drug Application (ANDA) for...
Lynk Pharmaceuticals announces NDA acceptance for zemprocitinib
Lynk Pharmaceuticals, a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, has announced that the New Drug Application (NDA)...
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Eli Lilly and Company and Centessa Pharmaceuticals, a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other...
Clinical Trials Insight
Renaissance Pharma secures FDA Fast Track Designation and IND clearance for Daretabart in high-risk neuroblastoma
The US Food and Drug Administration (FDA) has granted Fast Track Designation for Daretabart (hu1418K322A), a novel anti-GD2 monoclonal antibody in development for the...
AbbVie’s Elahere succeeds in phase 2 platinum-sensitive ovarian cancer trial
AbbVie has announced that late-breaking results from the phase 2 IMGN853-0420 trial.
The study evaluated the potential efficacy and safety of mirvetuximab soravtansine-gynx, a first-in-class antibody-drug...
Oragenics doses first patient in phase 2a clinical trial of drug for mild traumatic brain injury
Oragenics, a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, has announced that the first patient has been dosed in its...
Lynk Pharmaceuticals announces NDA acceptance for zemprocitinib
Lynk Pharmaceuticals, a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, has announced that the New Drug Application (NDA)...
MetaVia doses the first patient in higher-dose phase 1 study of DA-1726, Its GLP-1 and glucagon dual agonist for the treatment of obesity
MetaVia, a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, has announced that the first patient has been dosed in part 3 of its...
VIDEOS
Pharma in Healthcare
Cell line development market to reach $8.95 billion by 2031 with Gene & Cell Therapy manufacturing growing at 10.88%
According to Mordor Intelligence, the global cell line development market is projected to grow from USD 4.97 billion in 2025 to USD 5.48 billion in 2026, and is expected to...
Romaco Group appoints Nicola Magriotis as Chief Sales Officer
The advisory board of Romaco Holding GmbH has appointed Nicola Magriotis as Chief Sales Officer (CSO) of the Romaco Group. By creating this new managerial...
New report finds FDA costs soaring and drug rejections rising
The Taxpayers Protection Alliance released a report, called Blocking Breakthroughs: Delays and Denials at the FDA, that highlights the many issues with the Food and Drug...
FDA approves Novo Nordisk’s Awiqli, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes
The US Food and Drug Administration (FDA) has approved Novo Nordisk's Awiqli® (insulin icodec-abae) injection 700 units/mL, the first and only once-weekly, long-acting basal insulin,...
Global paediatric consumer health market to reach US$254 billion by 2032 amid growing focus on child wellness and nutrition
According to the latest market study published by Vyansa Intelligence, the global paediatric consumer health market is projected to grow at a CAGR of around 5%...
Technology and Automation
Liebherr expands UK lab portfolio
Commercial refrigeration specialist Liebherr has introduced seven high performance countertop and fully integrated under bench models in their UK lab and healthcare range.
These include...
START partners with Trialing to expand access to oncology clinical trials across Europe
The START Center for Cancer Research (START), the world’s largest community-based network of clinical trial sites specialising in early-phase oncology trials, has announced a strategic...
Touch Taiwan 2026: AUO Group opens a new chapter in display innovation with AUO Display Plus Driving AI and Green Vertical Applications
As a global leader in display technologies and solutions, AUO leverages group‑wide strengths to continuously advance deployment across vertical applications. At Touch Taiwan 2026,...
Next-generation cryogenic transmission electron microscope –Glacios 3 Cryo-TEM launched
Thermo Fisher Scientific, a world leader in serving science, has introduced a next-generation cryogenic transmission electron microscope (cryo-TEM) designed to help scientists understand structural...
AI agents to accelerate field excellence in life sciences with intelligent workflow automation
ACTO AI, a powerful new suite of 17 AI workflow agents designed to streamline and automate critical tasks across the ACTO platform, has been launched.
Built...
Pharma packaging and logistics
4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility...
4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, has announced a significant expansion into a new innovation hub...
Delivery routes expanded and order cut-off times for midwest and west coast customers extended
Smith Drug Company, the industry's largest wholesaler dedicated exclusively to independent retail and long-term care pharmacies, has announced a series of operational enhancements designed...
Atelerix enters agreement with Cherry Biotech to integrate non-cryogenic transport solutions with advanced organoid models
Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has entered a partnership with...
Samsung Biologics expands US manufacturing capacity with acquisition from GSK
Samsung Biologics has announced that its wholly owned US subsidiary, Samsung Biologics America, has entered into a definitive agreement to acquire 100% of Human...
Natix goes to China to enhance manufacturing
To answer the global shortage of high-activity Pancrelipase/Pancreatin Enzybel Pharma 2, Natix has forged a strategic alliance with Deebio, a prominent Chinese manufacturer of...
Events and conferences
Global Drug Delivery and Formulation (DDF) Summit
18-20 May Berlin, Germany
The Global Drug Delivery and Formulation (DDF) Summit is Europe’s premier gathering for professionals at the forefront of pharmaceutical development and drug delivery...
Chemspec Europe reveals new details about 2026 conference programme
6–7 May 2026 Koln, Germany
Chemspec Europe has unveiled further details of its highly anticipated conference programme, offering attendees fresh insight into the key...
Inaugural International Brain Health Conference 2026 to focus on early intervention before dementia
International Brain Health Conference 2026 18–19 May 2026 Sheraton Grand Hotel, Edinburgh, UK
An international conference bringing together global leaders in neuroscience, clinical research, public health, and...
Major growth in visitor numbers, full halls, clear future topics: Analytica 2026 sets standards
1,135 exhibitors from 40 countries
About 35,000 visitors from 115 countries
AI and automation as innovation drivers for the industry
Full halls, more visitors, highly satisfied exhibitors:...
Interphex week Tokyo 2026 conference programme announced
Featuring 320 sessions across manufacturing, quality, CMC, and digital transformation, the conference programme for Interphex week Tokyo 2026, Japan’s largest pharma and biotech gathering...
Funding and Finance
Evotec Appoints Dr Ingrid Müller as Chief Operating Officer
Evotec has announced the appointment of Dr Ingrid Müller as Chief Operating Officer (COO). Dr Müller will be joining Evotec’s Management Board, effective 1...
Virica Biotech and Fujifilm Biosciences collaborate to develop production enhancers
Virica Biotech, a cell enhancer company specialising in Viral Sensitizers for viral vector manufacturing, has announced receipt of advisory services and funding from the...
Novartis agrees to acquire Excellergy, building on allergy leadership with next-generation anti-IgE innovation
Novartis has announced that it has entered into an agreement to acquire Excellergy, a private biotech company developing next-generation anti-IgE therapies for IgE-driven diseases....
Evotec to receive around $100 Million as part of Tubulis acquisition
Evotec SE has announced that it is expected to receive approximately $100 million in upfront consideration upon closing of the sale of Tubulis GmbH...
Thermo Fisher collaborates with HealthVerity to expand real-world data capabilities
Thermo Fisher Scientific, the world leader in serving science, has announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) marketplace, to...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
MOST POPULAR POSTS
© 2026 Pharma Press Publishing.